4/A//SEC Filing
Leider Harry L. 4/A
Accession 0001829126-23-008158
CIK 0001557376other
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 4:01 PM ET
Size
7.0 KB
Accession
0001829126-23-008158
Insider Transaction Report
Form 4/AAmended
Leider Harry L.
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2023-06-29$0.01/sh+500,000$5,000→ 1,049,450 total(indirect: See footnote) - Purchase
Common Stock
2023-06-28$0.01/sh+549,450$5,440→ 549,450 total(indirect: See footnote)
Footnotes (1)
- [F1]The shares are held by the Harry L. Leider Revocable Trust of which the Reporting Person is the Trustee. The purpose of this Amendment is to correct the purchase price for the shares purchased on June 28, 2023.
Documents
Issuer
Organicell Regenerative Medicine, Inc.
CIK 0001557376
Entity typeother
Related Parties
1- filerCIK 0001888273
Filing Metadata
- Form type
- 4/A
- Filed
- Dec 20, 7:00 PM ET
- Accepted
- Dec 21, 4:01 PM ET
- Size
- 7.0 KB